1. Home
  2. /
  3. Accessibility
  4. /
  5. Optimising DTwP-containing vaccine infant immunisation schedules in Uganda and Nepal (OptImms)

Optimising DTwP-containing vaccine infant immunisation schedules in Uganda and Nepal (OptImms)

Description

Evaluates alternative infant immunisation schedules in Uganda and Nepal to determine whether reduced-dose or delayed schedules can maintain adequate protection while creating space in routine immunisation programmes for the introduction of new vaccines.
TB vaccine theme
Accessibility
Implementation strategies and feasibility, Policy and frameworks

Project details

Country
Nepal, Uganda
Timeline
2021-2025
Target group
Infants
Vaccine
DTwP-Hib-HepB vaccine
Type of protection of vaccine
Prevention of disease
Type of research
Clinical, quantative
Partners involved
Gates Foundation, MRC/UVRI and LSHTM Uganda Research Unit, National Institute for Public Health and the Environment (RIVM), NIHR Oxford Biomedical Research Centre, Oxford Vaccine Group, Patan Academy of Health Sciences, Radboud University Medical Centre, Tribhuvan University, University of Oxford
Type of project
research
Funder
Civil Society
Governmental Body

Resources

Optimising DTwP-containing vaccine infant immunisation schedules in Uganda and Nepal (OptImms): two open-label, non-inferiority, randomised controlled trials

Contact

Xinxue Liu
Xinxue.liu@paediatrics.ox.ac.uk
Click to copy link of this header Menu